Weight loss drugs are more likely to be covered on government-funded insurance than on private plans
New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...
Medicaid dominates coverage of Novo, Lilly weight-loss drugs
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
New Weight Loss Drug Boosts Energy and Reduces Appetite Without Side Effects
Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...
Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
Exclusive-Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...